<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">

    <title>Nov 16, 2015 Comparison: Yellow Fever &amp; Hepatitis</title>

    <link href="../css/bootstrap.min.css" rel="stylesheet">
    <link href="../css/w210.css" rel="stylesheet">
    <!--[if lt IE 9]>
        <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
        <script src="https://oss.maxcdn.com/libs/respond.js/1.4.2/respond.min.js"></script>
    <![endif]-->

</head>

<body>

    <nav class="navbar navbar-inverse navbar-fixed-top" role="navigation">
        <div class="container">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1">
                    <span class="sr-only">Toggle navigation</span>
                    <span class="icon-bar"></span>
                </button>
                <a class="navbar-brand" href="../dashboard/dashboard_20151116.html">Early Warning</a>
            </div>
            <div class="collapse navbar-collapse" id="bs-example-navbar-collapse-1">
                <ul class="nav navbar-nav">
                    <li>
                        <a href="../dashboard/dashboard_20151116.html">Dashboard</a>
                    </li>
                </ul>
            </div>
        </div>
    </nav>

    
    <div class="container">

        <div class="row">
            <div class="col-lg-12">
                <h1 class="page-header">Case Comparison
                    <small><a href="yello_hepat_20151115.html"><span class="glyphicon glyphicon-arrow-left"></span></a> Nov 16, 2015 <a href="yello_hepat_20151117.html"><span class="glyphicon glyphicon-arrow-right"></span></a></small>
                </h1>
            </div>
        </div>


        <div class="row">
            <div class="col-md-1 portfolio-item">
                &nbsp;
            </div>
            
            
            <div class="col-md-4 portfolio-item">
                <h1>Yellow Fever</h1>
                <p><a href="../detail_view/yello_20151116.html">return to detail view</a></p>
                
                <h3>30-Day Web Trend</h3>
                <p>
                    1 <font color="red">alerts</font>, 0 <font color="orange">warnings</font>
                    <br/>
                	<img class="no-responsive" src="../images/qcc/yello_20151116_shewhart.png" alt="">
                </p>
                
                
                <h3>30-Day Twitter Trend</h3>
                <p>
                    0 <font color="red">alerts</font>, 0 <font color="orange">warnings</font>
                    <br/>
                	<img class="no-responsive" src="../images/qcc_tweets/yello_20151116_shewhart.png" alt="">
                </p>
                
                
                <h3>Article Locations</h3>
                <img class="no-responsive" src="../images/geo/yello_20151116_geo.png" alt="">
                
                <h3>Article Confidences</h3>
                <img class="no-responsive" src="../images/hist/yello_20151116_hist.png" alt="">
                
                
                
                
                <h3>Top Articles:</h3>
                <div class="detail_scrollable">
                    <dl>
                        <i>No articles found for Nov 16, 2015</i>
                    </dl>
                </div>
                <p>&nbsp;</p>
                
                <h3>Top Tweets:</h3>
                <div class="detail_scrollable">
                    <dl>
                        <i>No tweets found for Nov 16, 2015</i>
                    </dl>
                </div>
            </div>
            
            
            <div class="col-md-1 portfolio-item">
                &nbsp;
            </div>
            
            
            <div class="col-md-4 portfolio-item">
                <h1>Hepatitis</h1>
                <p><a href="../detail_view/hepat_20151116.html">return to detail view</a></p>
                
                
                <h3>30-Day Web Trend</h3>
                <p>
                    0 <font color="red">alerts</font>, 0 <font color="orange">warnings</font>
                    <br/>
                	<img class="no-responsive" src="../images/qcc/hepat_20151116_shewhart.png" alt="">
                </p>
                
                
                <h3>30-Day Twitter Trend</h3>
                <p>
                    0 <font color="red">alerts</font>, 0 <font color="orange">warnings</font>
                    <br/>
                	<img class="no-responsive" src="../images/qcc_tweets/hepat_20151116_shewhart.png" alt="">
                </p>
                
                
                <h3>Article Locations</h3>
                <img class="no-responsive" src="../images/geo/hepat_20151116_geo.png" alt="">
                
                <h3>Article Confidences</h3>
                <img class="no-responsive" src="../images/hist/hepat_20151116_hist.png" alt="">
                
                
                
                
                <h3>Top Articles:</h3>
                <div class="detail_scrollable">
                    <dl>
                        <dt>0.966</dt><dd><a href="http://www.independent.co.ug/features/features/10790-hepatitis-b">Hepatitis B</a></dd>
<dt>0.877</dt><dd><a href="https://idw-online.de/de/news641587">Hepatitis E virus superinfection and clinical progression in hepatitis B patients</a></dd>
<dt>0.877</dt><dd><a href="http://www.vinereport.com/article/hepatitis.c.investigations.potential.exposure.in.2nd.u.s.hospital.one.step.testing.developed/4780.htm">Hepatitis C investigations:2nd U.S. hospital may be affected; one-step testing developed</a></dd>
<dt>0.695</dt><dd><a href="http://www.marketwatch.com/story/janssen-presents-new-data-assessing-olysio-simeprevir-in-combination-with-sofosbuvir-in-genotype-4-infected-hcv-patients-in-egypt-2015-11-16">Janssen Presents New Data Assessing OLYSIO® (Simeprevir) in Combination with Sofosbuvir in Genotype 4 Infected HCV Patients In Egypt</a></dd>
<dt>0.671</dt><dd><a href="http://finance.yahoo.com/news/janssen-presents-data-assessing-olysio-104400739.html">Janssen Presents New Data Assessing OLYSIO® (Simeprevir) in Combination with Sofosbuvir in Genotype 4 Infected HCV Patients In Egypt</a></dd>
<dt>0.669</dt><dd><a href="http://iberonews.com/not_det.php?lang=es&notid=58113">Janssen Presents New Data Assessing OLYSIO® (Simeprevir) in Combination with Sofosbuvir in Genotype 4 Infected HCV Patients In Egypt</a></dd>
<dt>0.664</dt><dd><a href="http://iberonews.com/not_det.php?lang=es&notid=58116">Pharco Pharmaceuticals Inc. ha anunciado que ravidasvir ha alcanzado una tasa de curación del 100% cuando se combina con sofosbuvir en pacientes con VHC, sin cirrosis, de genotipo 4</a></dd>
<dt>0.649</dt><dd><a href="http://www.finanztreff.de/news/business-wire-janssen-presents-new-data-assessing-olysio-simeprevir-in-combination-with-so/10900525">Janssen Presents New Data Assessing OLYSIO® (Simeprevir) in Combination with Sofosbuvir in Genotype 4 Infected HCV Patients In Egypt</a></dd>
<dt>0.649</dt><dd><a href="http://pipelinereview.com/index.php/2015111659560/Small-Molecules/Janssen-Presents-New-Data-Assessing-OLYSIOR-Simeprevir-in-Combination-with-Sofosbuvir-in-Genotype-4-Infected-HCV-Patients-In-Egypt.html">Janssen Presents New Data Assessing OLYSIO(R) (Simeprevir) in Combination with Sofosbuvir in Genotype 4 Infected HCV Patients In Egypt</a></dd>
<dt>0.611</dt><dd><a href="http://www.medicalnewstoday.com/releases/302650.php">Large study sums up health issues for new child refugees to US</a></dd>
<dt>0.525</dt><dd><a href="http://www.eyeontaiwan.com/childrens-health-booklet-errors-draw-criticism">Children’s Health Booklet errors draw criticism</a></dd>
<dt>0.521</dt><dd><a href="http://www.businesswire.com/news/home/20151116005544/en/Global-Partners-Announce-Donation-500-Millionth-Dose">Global Partners Announce Donation of 500 Millionth Dose of Azithromycin, Marking Exceptional Progress to Help Alleviate the Suffering from Trachoma</a></dd>
                    </dl>
                </div>
                <p>&nbsp;</p>
                
                <h3>Top Tweets:</h3>
                <div class="detail_scrollable">
                    <dl>
                        <i>No tweets found for Nov 16, 2015</i>
                    </dl>
                </div>
            </div>
        </div>



        <footer>
            <div class="row">
                <div class="col-lg-12">
                    <p class="authors">MIDS Capstone: David Rose, Wei Shi, Chris Walker</p>
                </div>
            </div>
        </footer>

    </div>

    <script src="../js/jquery.js"></script>
    <script src="../js/bootstrap.min.js"></script>

</body>

</html>
